4:12 pm Seattle Genetics beats by $0.11, beats on revs; Data anticipated in 2014 from ADCETRIS Phase 3 AETHERA trial and SGN-CD19A and SGN-CD33A pipeline programs – HedgeChatter

4:12 pm Seattle Genetics beats by $0.11, beats on revs; Data anticipated in 2014 from ADCETRIS Phase 3 AETHERA trial and SGN-CD19A and SGN-CD33A pipeline programs

11 Feb

4:12 pm Seattle Genetics beats by $0.11, beats on revs; Data anticipated in 2014 from ADCETRIS Phase 3 AETHERA trial and SGN-CD19A and SGN-CD33A pipeline programs

Bystocknews SGEN, stock Comments Off

View todays social media effects on SGEN

View the latest stocks trending across Twitter. Click to view dashboard

See who Seattle is hiring next, click here to view

Author